COMMUNIQUÉS West-GlobeNewswire

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
12/12/2025
First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation in Alzheimer’s Patient on Leqembi ® (Lecanemab) Anti-Amyloid Therapy BOSTON, Dec. 12, 2025 ( [...]
Anavar Steroid 2026: Legal Steroid Alternative, Anavar For Women Cycle, Dosage, Side Effects, Anavar Before And After Result (Anavar for Sale) Launch Alternative Anvarol By CrazyBulk
12/12/2025
Anavar Steroid: Cycle, Dosage, Side Effects, Most Popular Legal Steroids (Before And After Anavar Result) - Anavar for women (Anavar for Sale) - Buy Alternative Anvarol From CrazyBulk New York City,, Dec. 12, 2025 ( [...]
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
12/12/2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing [...]
DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference
12/12/2025
LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Dr. Walter Jacobson, a Los Angeles-based psychiatrist, author, and first-time filmmaker, scored a major win at this year’s American Film Market (AFM) Pitch Conference when [...]
Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup
12/12/2025
– Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful of 2025 by JAMA [...]
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
12/12/2025
Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel [...]
Novartis breaks ground on flagship manufacturing hub in North Carolina
12/12/2025
FDA Commissioner Marty Makary, North Carolina Governor Josh Stein and Novartis leadership highlight importance of new hub to US patients and local economy Construction reflects company’s commitment to ensure end-to-end [...]
BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years
12/12/2025
– ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides child-friendly method of administration- –Showed early and sustained reductions [...]
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
12/12/2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib) was [...]
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
12/12/2025
Efficacy data remain consistent with previous disclosures, showing 10.3-month median PFS in all patients and 11.4-month median PFS in 2L patients Subset analyses show broad activity in patients with PI3Kα-mutated, HR+/ [...]
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
12/12/2025
Across multiple published studies, the test consistently identifies high-risk patients whose progression rates exceed guideline-based actionable thresholds for intensified care FRIENDSWOOD, Texas, Dec. 12, 2025 (GLOBE [...]
Nova Leap Health Corp. Grants Stock Options
12/12/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
12/12/2025
BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]
Harold Health Launches New Telehealth Platform Supporting Men’s Mental and Physical Well-being
12/12/2025
New HIPAA and HL7 compliant app offers a holistic approach to men's health with on-demand providers, community support, and cutting-edge mental health and wellness therapies Miami, Florida, Dec. 12, 2025 (GLOBE NEWSWIRE [...]
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
12/12/2025
Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement in 2L/3L EGFR WT [...]
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
12/12/2025
On track to file a Clinical Trial Application (CTA) by year end 2025, with initial clinical data expected mid-2026 Important step in developing scalable and accessible ‘off-the-shelf’ cell therapy for patients with [...]
Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure
12/12/2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) (the “Company” or “Axe Compute”) today announced that it has changed its name to Axe Compute Inc., with its common stock to begin trading on [...]
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
12/12/2025
This agreement expands RadioMedix’s access to essential 228 Th resources, strengthening the Company’s 212 Pb pipeline and generator platform for its long-term Targeted Alpha Therapy strategy HOUSTON, Dec. 12, 2025 ( [...]
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best [...]

Pages